You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 146 No. 7, July 1986 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL INVESTIGATIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (11)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Mitral Valve Prolapse in Psoriatic Arthritis

Amos Pines, MD; Michael Ehrenfeld, MD; Enrique Z. Fisman, MD; Naomi Kaplinsky, MD; Yecheskel Samra, MD; Meir Ronnen, MD; Jan J. Kellermann, MD

Arch Intern Med. 1986;146(7):1371-1373.


Abstract



• Twenty-five patients with psoriatic arthritis were studied by echocardiography in view of the known association of related seronegative arthropathies with aortic-valve lesions. The study group included 15 men and ten women with a mean age of 46.5 ±14.6 years. Twenty-two patients suffered from peripheral disease whereas three also had axial involvement. No aortic-valve lesions were found; however, mitral-valve prolapse (MVP) was detected in 14 patients (56%), nine men and five women. The mean age, mean duration of psoriasis, and mean duration of arthritis were similar in patients with and without MVP. HLA tissue typing, which was done in nine patients with MVP, revealed only one patient with HLA-B27. There was no predominance of any of the typical antigens found in psoriasis (HLA-B13, HLA-Cw6). In a control group of 32 psoriatic patients without arthritis, only two (6.4%) suffered from MVP.

(Arch Intern Med 1986;146:1371-1373)



Author Affiliations



From the Departments of Medicine (Drs Pines, Ehrenfeld, Kaplinsky, and Samra) and Dermatology (Dr Ronnen) and the Cardiac Rehabilitation Institute (Drs Fisman and Kellermann), Chaim Sheba Medical Center, Tel Hashomer, and Sackler School of Medicine, Tel Aviv University, Israel.


Footnotes



Accepted for publication Nov 4,1985.

Reprint requests to Department of Medicine "F," Chaim Sheba Medical Center, 52621 Tel Hashomer, Israel (Dr Pines).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

35th Annual Meeting -- American College of Angiology Orlando, Florida -- October, 1988 Symposium Proceedings: Neurologic Aspects of Mitral Valve Prolapse
Heck
ANGIOLOGY 1989;40:743-751.
ABSTRACT  

Mitral Valve Prolapse (MVP) in Psoriatic Arthritis (PA)
Moya et al.
Arch Intern Med 1987;147:992-992.
ABSTRACT  

Mitral Valve Prolapse (MVP) in Psoriatic Arthritis (PA)-Reply
Ehrenfeld et al.
Arch Intern Med 1987;147:992-992.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.